(NASDAQ: TNDM) Tandem Diabetes Care's forecast annual revenue growth rate of 9.1% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Tandem Diabetes Care's revenue in 2025 is $940,203,000.On average, 7 Wall Street analysts forecast TNDM's revenue for 2025 to be $66,580,892,227, with the lowest TNDM revenue forecast at $66,206,049,447, and the highest TNDM revenue forecast at $66,938,584,904. On average, 7 Wall Street analysts forecast TNDM's revenue for 2026 to be $74,046,771,299, with the lowest TNDM revenue forecast at $72,322,255,203, and the highest TNDM revenue forecast at $77,029,227,594.
In 2027, TNDM is forecast to generate $81,039,161,254 in revenue, with the lowest revenue forecast at $78,544,618,775 and the highest revenue forecast at $83,158,063,272.